Health Care: Drugs

Athersys Inc (ATHX: NASDAQ)

$1.58 -0.1 | -5.95%
06/22/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.68
52 Week High 2.35
52 Week Low 1.02
Avg. Daily Vol. (Mil) 1.39
Beta (3 year) -0.50
Share Related Items
Mkt Cap (Mil) 187.01
Shares Out (Mil) 111.32
Float (Mil) 103.49
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.20
Current Ratio 2.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.78
Price/Book 16.73
Price/Cash Flow -12.50
Per Share Data
Earnings -0.18
Sales 0.16
Book Value 0.10
Cash Flow -0.13
Business Summary
Athersys Inc is a biopharmaceutical company developing regenerative medicine. It is engaged in the discovery and development of therapies designed to extend and enhance human life.
General Information
3201 Carnegie Avenue
Cleveland, OH 44115-2634
Industry : Drugs
Sector: Health Care
Employees: 60
CEO: Dr. Gil Van Bokkelen
Short Interest
Current Month (Mil) 5.52
Previous Month (Mil) 5.67
Short Interest Ratio (Days) 9.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -80.50
Return on Investments -137.20
Gross Margin n.a.
EBIT Margin -88.60
Profit Margin -88.40

Portfolios with ATHX

Latest ATHX Headlines from TheStreet

More Financial News for ATHX

Press Releases for ATHX

See All Press Releases

Partner Headlines for ATHX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter